Ishita Drugs & Industries Ltd
₹76.54
(-4.86%)
Thu, 12 Mar 2026, 01:23 am
Health Technology
Pharmaceuticals: Other
24.5KIshita Drugs & Industries Debt to Equity Ratio
| Particulars | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 6.50 | 15.54 | 31.49 | 34.93 | 11.79 | 21.69 | 23.11 | 31.20 | 32.79 | 27.05 | 12.46 | 5.98 | 10.81 | 15.36 | 25.59 | 26.20 | 27.05 |
| Price to book ratio | 0.71 | 1.55 | 2.78 | 1.60 | 1 | 0.86 | 0.96 | 0.78 | 1.06 | 1.14 | 0.68 | 0.47 | 1.15 | 1.44 | 1.61 | 1.98 | 2.18 |
| Price to sales ratio | 0.56 | 1 | 1.54 | 1.45 | 0.42 | 0.65 | 0.73 | 0.66 | 1.02 | 1 | 0.48 | 0.22 | 0.64 | 0.88 | 1.22 | 1.29 | 1.57 |
| Price to cash flow ratio | 2.39 | 68.61 | 240.68 | 7.51 | 0 | 5.36 | 22.99 | 11.95 | 9.54 | 9.21 | 4.92 | 2.79 | 0 | 3.92 | 0 | 8.48 | 0 |
| Enterprise value | 12.84M | 48.42M | 120.43M | 48.12M | 29.44M | 18.65M | 24M | 12.28M | 23.39M | 26.5M | -3.04M | -25.24M | 35.9M | 38.9M | 91.88M | 117.35M | 190.4M |
| Enterprise value to EBITDA ratio | 2.22 | 8 | 19.97 | 17.85 | 5.44 | 4.13 | 7.74 | 4.47 | 6.49 | 6.70 | -0.59 | -3.31 | 3.91 | 3.56 | 12.06 | 12.92 | 19.01 |
| Debt to equity ratio | 0.01 | 0.02 | 0.08 | 0.01 | 0.04 | 0.04 | 0.02 | 0.21 | 0 | 0.02 | 0.03 | 0.04 | 0.01 | 0 | 0.10 | 0 | 0.36 |
| Return on equity % | 0 | 10.28 | 9.35 | 4.64 | 8.87 | 4.07 | 4.23 | 2.53 | 3.27 | 4.28 | 5.70 | 8.18 | 11.25 | 9.82 | 6.50 | 7.84 | 8.38 |
Ishita Drugs & Industries Ltd Debt to Equity Ratio
The Ishita Drugs & Industries Ltd Debt to Equity Ratio is a key financial metric used by investors to evaluate Ishita Drugs & Industries Ltd's valuation, profitability, and overall financial performance. Tracking the Ishita Drugs & Industries Ltd Debt to Equity Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Ishita Drugs & Industries Ltd (NSE: , BSE: 524400) is currently trading at ₹76.54, with a market capitalization of ₹240.57M. As a leading company in the Health technology sector and Pharmaceuticals: other industry, monitoring the Ishita Drugs & Industries Ltd Debt to Equity Ratio is essential for fundamental analysis.
Ishita Drugs & Industries Ltd Debt to Equity Ratio Current Value
The current Ishita Drugs & Industries Ltd Debt to Equity Ratio stands at 0.36.
The latest Ishita Drugs & Industries Ltd Debt to Equity Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Ishita Drugs & Industries Ltd Debt to Equity Ratio Historical Trend
The Ishita Drugs & Industries Ltd Debt to Equity Ratio has shown the following historical trend:
- 2024: 0.36
- 2023: 0
- 2022: 0.10
- 2021: 0
- 2020: 0.01
The recent rise in Ishita Drugs & Industries Ltd Debt to Equity Ratio suggests strengthening valuation trends and improving market sentiment.
What Ishita Drugs & Industries Ltd Debt to Equity Ratio Indicates for Investors
The Ishita Drugs & Industries Ltd Debt to Equity Ratio plays a crucial role in understanding the company's financial health and valuation.
The D/E ratio measures financial leverage and balance sheet strength.
Ishita Drugs & Industries Ltd Debt to Equity Ratio Analysis Summary
The Ishita Drugs & Industries Ltd Debt to Equity Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Ishita Drugs & Industries Ltd Debt to Equity Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Ishita Drugs & Industries Ltd Debt to Equity Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800